| Employees |
Schedule
of number of employees
| |
|
Year ended December 31,
|
|
|
Year ended December 31,
|
|
|
Year ended December 31,
|
|
| |
|
2021 Number
|
|
|
2020 Number
|
|
|
2019 Number
|
|
| Number of employees |
|
|
|
|
|
|
|
|
|
|
|
|
| Average monthly number or persons (including directors) employed by the Group: |
|
|
|
|
|
|
|
|
|
|
|
|
| Research and development |
|
|
61 |
|
|
|
66 |
|
|
|
83 |
|
| Management, administration and operations |
|
|
8 |
|
|
|
13 |
|
|
|
11 |
|
| Number
of employees |
|
|
69 |
|
|
|
79 |
|
|
|
94 |
|
Management
includes employees who are involved in both research and development and administrative operations.
Schedule
of staffing costs
| |
|
Year ended December 31,
|
|
|
Year ended December 31,
|
|
|
Year ended December 31,
|
|
| |
|
2021 |
|
|
2020 |
|
|
2019 |
|
| |
|
£ |
|
|
£ |
|
|
£ |
|
| Staff costs – included in research and development |
|
|
|
|
|
|
|
|
|
|
|
|
| Wages and salaries |
|
|
2,989,066 |
|
|
|
3,443,726 |
|
|
|
3,663,845 |
|
| Social security costs |
|
|
313,138 |
|
|
|
386,063 |
|
|
|
411,114 |
|
| Pension costs – defined contribution |
|
|
94,938 |
|
|
|
130,339 |
|
|
|
145,223 |
|
| Share based payments |
|
|
- |
|
|
|
316,259 |
|
|
|
373,414 |
|
| Total staff costs |
|
|
3,397,142 |
|
|
|
4,276,387 |
|
|
|
4,593,596 |
|
| Staff costs – included in administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
| Wages and salaries |
|
|
877,752 |
|
|
|
703,366 |
|
|
|
766,107 |
|
| Social security costs |
|
|
56,646 |
|
|
|
99,040 |
|
|
|
82,236 |
|
| Pension costs – defined contribution |
|
|
42,034 |
|
|
|
24,548 |
|
|
|
38,372 |
|
| Share based payments |
|
|
- |
|
|
|
256,803 |
|
|
|
462,378 |
|
| Total staff costs |
|
|
976,432 |
|
|
|
1,083,757 |
|
|
|
1,349,093 |
|
| Staff costs – combined |
|
|
|
|
|
|
|
|
|
|
|
|
| Wages and salaries |
|
|
3,866,818 |
|
|
|
4,147,091 |
|
|
|
4,429,952 |
|
| Social security costs |
|
|
369,784 |
|
|
|
485,102 |
|
|
|
493,350 |
|
| Pension costs – defined contribution |
|
|
136,972 |
|
|
|
154,887 |
|
|
|
183,595 |
|
| Share based payments |
|
|
- |
|
|
|
573,062 |
|
|
|
835,792 |
|
| Total staff costs |
|
|
4,373,574 |
|
|
|
5,360,142 |
|
|
|
5,942,689 |
|
TC
BIOPHARM (HOLDINGS) PLC
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Schedule
of directors remuneration
Directors’
remuneration |
|
Year ended December 31,
|
|
|
Year ended December 31, |
|
|
Year ended December 31,
|
|
| |
|
2021 |
|
|
2020 |
|
|
2019 |
|
| |
|
£ |
|
|
£ |
|
|
£ |
|
| Directors’ remuneration in respect of qualifying services |
|
|
1,046,324 |
|
|
|
967,651 |
|
|
|
676,557 |
|
| Directors’ employer’s pension contributions |
|
|
15,001 |
|
|
|
14,376 |
|
|
|
12,453 |
|
| Directors remuneration |
|
|
1,061,325 |
|
|
|
982,027 |
|
|
|
689,010 |
|
The
total remuneration of the highest paid or receivable by the highest paid director in the year ended December 31, 2021 was £332,468
(2020: £365,194 and 2019: £294,259). The Group pension contributions in respect of the highest paid director totaled £Nil
for the year to December 31, 2021 (2020: £Nil and 2019: £8,111). The highest paid director did not exercise any share options
in the period. No other directors exercised share options in the period.
|